Literature DB >> 5564844

Radiobiolgoical and biochemical studies of thiophosphate radioprotective compounds related to cysteamine.

J W Harris, T L Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5564844

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  11 in total

1.  Molecur mechanism of action of the radioprotective substance WR 2721.

Authors:  A Hahn
Journal:  Radiat Environ Biophys       Date:  1975       Impact factor: 1.925

Review 2.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

Review 3.  Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.

Authors:  C M Spencer; K L Goa
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

4.  Radioprotection by WR-2721 in vitro at low oxygen tensions: implications for its mechanisms of action.

Authors:  R E Durand
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640

5.  Effect of diethyldithiocarbamate on toxicity of doxorubicin, cyclophosphamide and cis-diamminedichloroplatinum (II) on mice haemopoietic progenitor cells.

Authors:  I M Pannacciulli; R A Lerza; G V Bogliolo; M P Mencoboni; A G Saviane
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

6.  Amifostine alleviates radiation-induced lethal small bowel damage via promotion of 14-3-3σ-mediated nuclear p53 accumulation.

Authors:  Eng-Yen Huang; Feng-Sheng Wang; Yu-Min Chen; Yi-Fan Chen; Chung-Chi Wang; I-Hui Lin; Yu-Jie Huang; Kuender D Yang
Journal:  Oncotarget       Date:  2014-10-30

7.  The protective effects of Resveratrol against radiation-induced intestinal injury.

Authors:  Heng Zhang; Hao Yan; Xiaoliang Zhou; Huaqing Wang; Yiling Yang; Junling Zhang; Hui Wang
Journal:  BMC Complement Altern Med       Date:  2017-08-16       Impact factor: 3.659

8.  Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.

Authors:  A Rojas; F A Stewart; J Denekamp
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

9.  A possible combination of hypoxic cell sensitizer with an oxic protector: implications for radiotherapy.

Authors:  D Krishnan; D R Singh; U Madhvanath
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

10.  Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.

Authors:  A Rojas; F A Stewart; J Denekamp
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.